IGFBP-rP3 may act as a growth stimulator for prostate cancer cells given that it is preferentially expressed in malignant cells (166)
Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network
Lu G, Nagbanshi M, Goldau N, et al
The compound also promotes fibroblast movement toward damaged sites, where these cells generate new tissue matrix and support wound closure
In Denmark, metformin-treated patients with a high household income were more likely to initiate second-line treatment with a GLP-1 RA compared to those with low household income, and this finding was consistent in a subgroup analysis irrespective of presence of cardiovascular disease [16]